No profile data available.
Phibro Animal Health Corporation (PAHC) is a healthcare company in the animal healthcare items industry, based in Teaneck, United States, with about 2,605 full-time employees.
It reported revenue of $1.52 billion for fiscal year 2026, up 17.1% from fiscal year 2025, and net income of $99.72 million. Its largest business segment, Animal Health, brought in 77% of segment revenue in fiscal year 2026; United States was the largest region with 58%. Its market capitalization was $1.56 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2026; market data as of October 9, 2026.
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Phibro Animal Health reported $1.52 billion in revenue for fiscal year 2026, up 17.1% from $1.30 billion in fiscal year 2025.
Animal Health, with $1.16 billion or 77% of segment revenue in fiscal year 2026. Next: Mineral Nutrition (19%) and Performance Products (5%).
United States: 58% of revenue by region in fiscal year 2026, followed by Latin America and Canada (22%).
$1.56 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (animal healthcare items) include Idexx Laboratories, Inc. (IDXX), Zoetis Inc. (ZTS), Elanco Animal Health Incorporated (ELAN), ImmuCell Corporation (ICCC).